View archived livestream
Aris MD uses diagnostic images (MRI, CT, X-ray, Ultrasound) to overlay over patients during surgery. The technology gives the surgeon a guided map of their patient’s anatomy and pathology or injury. This innovation shows the surgeon where to cut and–more importantly–where not to cut. With this map, surgeons know precisely where they are going just by looking at their patient. This saves time in the operating room, reduces the patient's time under anesthetic and saves lives.
View Aris MD's Presentation
Dimer UVC Innovations
GermFalcon®: Covid-19 Response, Recovery and Prevention of the Next Pandemic
In 2017 Dimer UVC Innovations introduced the GermFalcon®, so named because it is quite literally a winged predator of germs. This patented robot emits Ultraviolet “C” (UVC) light at a wavelength of 254 nm for peak germicidal effectiveness. The unique design allows rapid and thorough disinfection of all frequently touched services in an airplane cabin interior, including the passenger seating area, lavatories and galleys. The design is versatile enough to be used in aircraft with as few as 70 seats up to the largest wide-body aircraft currently flying.
View Dimer UVC Innovations' Presentation
iFirst Medical Technologies
Handheld Viral Test and Epidemiological Surveillance Network
iFirst Medical Technologies, a leader in handheld diagnostic devices, has begun rapid development of a nasal swab/blood tests for use with the handheld iFirst Analyzer™ to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. The iFirst Analyzer is a handheld diagnostic device, with onboard chemistry and optical analytics. It features integrated GPS and wireless transmission of results to the iFirst Cloud™. This technology makes effective public health surveillance possible through real-time, automated reporting and mapping of outbreak hotspots - informing authorities and enabling better containment of the spread of an epidemic or a pandemic.
View iFirst Medical Technologies' Presentation
Hydrogen Fuel Cell
Marie Inc. is a U.S. based GenCell partner providing innovative, sustainable fuel cell technology for off-grid and backup power solutions in support of governments and commercial Industry critical energy infrastructure.
View Marie Inc.'s Presentation
One Milo Inc.
Coronavirus SmartRapid™ Test
One Milo has developed a COVID-19 IgG IgM Smart-tech enabled qualitative immunoassay for the rapid detection of IgG and IgM antibodies to COVID-19 in human finger prick whole blood specimens. One Milo’s proprietary smart-tech-enabled technology seamlessly reports the test to the cloud. Medical professionals in centralized locations can review those results in real-time from point-of-care testing taking place anytime and anywhere. The ecosystem includes clinical analytics for all tests, and results are ready to be read within ten minutes.
View One Milo Inc.'s Presentation
Antimicrobial/Viral 3D Printer Filament for Device Manufacturing
OrganicNANO's primary business is the development and commercializing of bioMEMS Lab-on-Chip devices, halloysite nanotube (HNT) enabled technology, 3D printed medical devices, 3D bio-printed tissues, dental and orthopedic implants, orthobiologics and anti-infective medical devices. The company's mission is to develop bioactive therapeutics that prevent infection and advance tissue repair and regeneration at the nanoscale using biocompatible and green biomaterials.
View organicNANO's Presentation
Patientory's COVID-19 Solution
Patientory believes in the future of a distributed technology ecosystem and is the leading provider of dApp blockchain solutions for health care. They use the open-sourced distributed ledger technology and decentralized software architecture to store and manage health information in real time, facilitated by a blockchain-based token "PTOY." Patientory provides a real-time COVID-19 patient tracking and reporting tool. The tool evaluates users' current health conditions with a self-inspection quiz and features a diagnostic testing kit along with a diagnostic care treatment plan to share with telehealth providers. The mobile app also alerts users before they enter COVID-19 hot spots.
View Patientory Inc.'s Presentation
Qntfy’s tech sheds light on many tactical and strategic challenges induced by COVID-19. Quinn will improve the population's mental health as we navigate isolation and recovery, as well as health care professionals currently supporting the pandemic. Quinn provides insight, suggestions and personalized support to individuals, guided by analytics on data from their everyday life that they opt-in (e.g., wearables and social media). The technology permits scalable deployment and rapid experimentation with the latest clinical academic findings. Quinn, with permission, uses de-identified, aggregated population-level views to make mental health quantified and visible to policymakers and stakeholders in real time.
View Qntfy's Presentation
Steelhead, designs, engineers and manufactures lightweight vessels for aerospace and terrestrial gas storage; but in light of the current crisis and resulting incidence of oxygen supply shortages, Steelhead is performing a manufacturing base pivot to manufacture large, high‐pressure medical oxygen containers to battle COVID‐19. Once completed, this technology will also be applicable for human-crewed space missions that need lightweight, bulk oxygen storage.
View Steelhead Composites' Presentation
Ex-Vivo Organ Support System
Tevosol is a medical device company developing EVOSS™ (Ex-Vivo Organ Support System), a portable and affordable warm perfusion machine that is the size and weight of the cold static storage cooler. By presenting a naturally functioning organ for complete evaluation, EVOSS will help surgeons transplant more organs from more donors. Tevosol's technological approach to achieve these goals is to build the body around the isolated organ and provide it with the necessary support to maintain and revitalize organ viability. Tevosol’s EVOSS has been developed as a multi-organ device, including hearts, lungs, livers, kidneys and composite vascular allografts (i.e., extremities).
View Tevosol's Presentation
As the entrepreneurial aerospace ecosystem continues to evolve, NASA recognizes that public-private partnerships produce greater impact. SBIR Ignite is a new way for small businesses that have a commercially-viable technology idea to use NASA as a stepping stone in their path towards commercial success. With a greater emphasis on commercialization, SBIR Ignite funds U.S. early-stage, high-risk technology development to help make companies and their technologies more attractive to private sector investors, customers, and partners.
NASA is fully committed to Diversity, Equity, Inclusion, and Accessibility (DEIA) for our entire workforce and all our workplaces.
Together, we can go further.
NASA iTech searches for and identifies advancements in technologies that are solving problems on Earth and have the potential to address existing challenges to enable NASA missions.
Join an elite group of inventors and entrepreneurs who have participated in this program. We're looking for innovations in Recycling for Optimum Space-Age Logistics and Low-Cost Photovoltaic Arrays for Space for the 2022 NASA iTech Focus Event.
Investors are a key part of the NASA iTech program. From being involved in evaluations and events, to getting some of the best deal-flow you'd ever imagine, if you are an investor we invite you to connect with us to learn how to get involved.
From aerospace to biotech, electronics manufacturers and more, we invite industry leaders to work with us. You will meet the most promising innovators out there. Our industry participants have sourced new partnerships and investments via NASA iTech.
Be Part of NASA iTech
Be the first to know about new NASA iTech challenges, events and other updates.
NASA’s Space Technology Mission Directorate
National Institute of Aerospace
The material contained in this document is based upon work supported by a National Aeronautics and Space Administration (NASA) grant or cooperative agreement. Any opinions, findings, conclusions or recommendations expressed in this material are those of the author and do not necessarily reflect the views of NASA.
© 2016-2022 NASA iTech/National Institute of Aerospace